Beijing Konruns Pharmaceutical Co Ltd
Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. The company offers agkistrodon acutus hemocoagulase under Suling trade name, a single-component hemocoagulase clinical hemostatic drug for surgical operations. It is also involved in the development of drug candidates, including ZY5301 that is in p… Read more
Beijing Konruns Pharmaceutical Co Ltd (603590) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.028x
Based on the latest financial reports, Beijing Konruns Pharmaceutical Co Ltd (603590) has a cash flow conversion efficiency ratio of 0.028x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥96.44 Million) by net assets (CN¥3.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing Konruns Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Beijing Konruns Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Beijing Konruns Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Konruns Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DOMS Industries Limited
NSE:DOMS
|
0.046x |
|
Sichuan Fulin Transportation Group Co Ltd
SHE:002357
|
0.006x |
|
Verallia
PA:VRLA
|
0.248x |
|
Guangzhou Amsky Technology Co Ltd
SHE:300521
|
-0.033x |
|
Beijing Dinghan Tech Co
SHE:300011
|
-0.016x |
|
Tengda Construction Group Co Ltd
SHG:600512
|
-0.002x |
|
Adriatic Metals PLC
PINK:ADTLF
|
-0.165x |
|
Orinko Advanced Plastics Co. Ltd. A
SHG:688219
|
N/A |
Annual Cash Flow Conversion Efficiency for Beijing Konruns Pharmaceutical Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Konruns Pharmaceutical Co Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.43 Billion | CN¥172.25 Million | 0.050x | -15.21% |
| 2023-12-31 | CN¥3.36 Billion | CN¥199.35 Million | 0.059x | +58.03% |
| 2022-12-31 | CN¥3.19 Billion | CN¥119.69 Million | 0.038x | +65.64% |
| 2021-12-31 | CN¥3.13 Billion | CN¥70.91 Million | 0.023x | +19.61% |
| 2020-12-31 | CN¥3.08 Billion | CN¥58.41 Million | 0.019x | -80.28% |
| 2019-12-31 | CN¥2.73 Billion | CN¥262.00 Million | 0.096x | -9.45% |
| 2018-12-31 | CN¥2.48 Billion | CN¥263.11 Million | 0.106x | -46.86% |
| 2017-12-31 | CN¥1.36 Billion | CN¥270.49 Million | 0.200x | +17.77% |
| 2016-12-31 | CN¥874.92 Million | CN¥148.26 Million | 0.169x | -39.63% |
| 2015-12-31 | CN¥683.27 Million | CN¥191.80 Million | 0.281x | +4.59% |
| 2014-12-31 | CN¥488.02 Million | CN¥130.98 Million | 0.268x | -48.62% |
| 2013-12-31 | CN¥313.45 Million | CN¥163.72 Million | 0.522x | -- |